Xprize has unveiled a new $5 million competition to encourage the development of rapid COVID-19 testing.
The non-profit organization on Tuesday announced the Xprize Rapid COVID Testing competition to "accelerate the development of high-quality COVID-19 testing that is low cost, easy to use, and fast-turnaround, enabling frequent testing." Xprize and OpenCovidScreen are asking the "world's brightest, most innovative minds" to get involved and develop new fast and affordable testing solutions that might help facilitate a safe return to school and work amid the pandemic, as other COVID-19 testing methods can take days to produce a result.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Today's political cartoons - March 8, 2025Cartoons Saturday's cartoons - trade wars, healthcare costs, and more
-
Marbled tea eggs recipeThe Week Recommends With a beautiful exterior, these eggs are also marked by their soft yolk
-
The Washington Post: kowtowing to Trump?Talking Point The newspaper's opinion editor has handed in his notice following edict from Jeff Bezos
-
Texas outbreak brings 1st US measles death since 2015Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
-
Mystery illness spreading in Congo rapidly kills dozensSpeed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
